Yellow fever virus. I. Development and evaluation of a plaque neutralization test
- PMID: 4973067
- PMCID: PMC547757
- DOI: 10.1128/am.16.11.1770-1775.1968
Yellow fever virus. I. Development and evaluation of a plaque neutralization test
Abstract
Heretofore, the most reliable way of measuring yellow fever virus antibody was to use the mouse neutralization (MN) test employing either suckling or weanling mice. Certain disadvantages (e.g., expense both of animals and of maintaining a mouse colony, allergic reactions of many laboratory workers, and the relatively long time, 21 days, before end points are reached) are inherent in any program with mice or other laboratory animal species and have discouraged the use of the MN test by many laboratories. A previously reported plaque neutralization (PN) test with primary chick embryo cell cultures could not be consistently reproduced by later investigators. We have developed a convenient and reproducible PN test employing the MA-104 embryonic rhesus monkey kidney cell culture and a single agar-overlay procedure. When compared with MN tests with newborn (1 to 3 days old) and weanling (16 to 20 g, 24 to 28 days old) mice inoculated by the intracranial route, the PN test was the most sensitive for measuring neutralizing antibody; it was also less variable, less costly, and it achieved results in the shortest period of time. End points could be determined in 5 to 6 days for the PN test as compared to 21 days for the MN test.
Similar articles
-
Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.Appl Microbiol. 1972 May;23(5):908-13. doi: 10.1128/am.23.5.908-913.1972. Appl Microbiol. 1972. PMID: 4624211 Free PMC article.
-
Yellow fever vaccine. II. Antigenicity and neurovirulence of a vaccine seed free from avian leukosis virus.Appl Microbiol. 1969 Jun;17(6):866-70. doi: 10.1128/am.17.6.866-870.1969. Appl Microbiol. 1969. PMID: 4307883 Free PMC article.
-
Yellow fever virus. II. Factors affecting the plaque neutralization test.Appl Microbiol. 1969 Nov;18(5):736-43. doi: 10.1128/am.18.5.736-743.1969. Appl Microbiol. 1969. PMID: 4984200 Free PMC article.
-
Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine.Appl Microbiol. 1973 Apr;25(4):539-44. doi: 10.1128/am.25.4.539-544.1973. Appl Microbiol. 1973. PMID: 4633476 Free PMC article.
-
Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.Vaccine. 1999 Apr 9;17(15-16):1869-82. doi: 10.1016/s0264-410x(98)00487-3. Vaccine. 1999. PMID: 10217584
Cited by
-
Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype.PLoS One. 2017 May 31;12(5):e0177882. doi: 10.1371/journal.pone.0177882. eCollection 2017. PLoS One. 2017. PMID: 28562615 Free PMC article.
-
Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010-2020.BMC Infect Dis. 2022 Apr 29;22(1):418. doi: 10.1186/s12879-022-07407-1. BMC Infect Dis. 2022. PMID: 35488234 Free PMC article.
-
Prospects for a Zika Virus Vaccine.Immunity. 2017 Feb 21;46(2):176-182. doi: 10.1016/j.immuni.2017.02.005. Immunity. 2017. PMID: 28228277 Free PMC article. Review.
-
Generation of a reporter yellow fever virus for high throughput antiviral assays.Antiviral Res. 2020 Nov;183:104939. doi: 10.1016/j.antiviral.2020.104939. Epub 2020 Sep 24. Antiviral Res. 2020. PMID: 32980446 Free PMC article.
-
Kinetics of the vaccinia virus plaque neutralization test.Appl Microbiol. 1971 May;21(5):968-70. doi: 10.1128/am.21.5.968-970.1971. Appl Microbiol. 1971. PMID: 4995735 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources